DCOY is trading at $6.80 (5.4% down) in after-hours as the stock extends a pullback following a sharp reversal from its June 29 private placement-driven rally.
- Shares are retreating as investors lock in gains following Decoy Therapeutics’ announcement of up to $21 million in financing, which had previously sent the stock sharply higher.
- The downward momentum is continuing into the after-hours session as the stock gives back a portion of its recent gains.